<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Belgium Archives - Global NIPT Consortium</title>
	<atom:link href="https://niptconsortium.com/category/belgium/feed/" rel="self" type="application/rss+xml" />
	<link>https://niptconsortium.com/category/belgium/</link>
	<description>Noninvasive Prenatal Testing (NIPT) Consortium</description>
	<lastBuildDate>Thu, 30 Nov 2023 18:26:57 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
	<item>
		<title>Outcome of publicly funded nationwide first-tier noninvasive prenatal screening</title>
		<link>https://niptconsortium.com/outcome-of-publicly-funded-nationwide-first-tier-noninvasive-prenatal-screening/</link>
		
		<dc:creator><![CDATA[NIPTadmin]]></dc:creator>
		<pubDate>Mon, 01 Feb 2021 02:02:57 +0000</pubDate>
				<category><![CDATA[2021]]></category>
		<category><![CDATA[Belgium]]></category>
		<category><![CDATA[Clinical Experience / Clinical Utility]]></category>
		<category><![CDATA[CNVs]]></category>
		<category><![CDATA[RAAs]]></category>
		<guid isPermaLink="false">https://niptconsortium.com/?p=9678</guid>

					<description><![CDATA[<p>Van Den Bogaert K, Lannoo L, Brison N, et al. Genet Med. 2021;23(6):1137-1142. doi:10.1038/s41436-021-01101-4. Open Access: Learn more Tags: Clinical Experience / Clinical Utility, 2021, Belgium, RAAs, CNVs Belgium was the first country to implement and fully reimburse NIPT as a first-tier screening for all pregnant women. In this publication, a consortium comprised of all [&#8230;]</p>
<p>The post <a href="https://niptconsortium.com/outcome-of-publicly-funded-nationwide-first-tier-noninvasive-prenatal-screening/">Outcome of publicly funded nationwide first-tier noninvasive prenatal screening</a> appeared first on <a href="https://niptconsortium.com">Global NIPT Consortium</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Van Den Bogaert K, Lannoo L, Brison N, et al. Genet Med. 2021;23(6):1137-1142. doi:10.1038/s41436-021-01101-4. Open Access: <a href="https://www.gimjournal.org/article/S1098-3600(21)05214-X/fulltext" target="_blank" rel="noopener">Learn more</a></p>
<p><strong><em>Tags:</em></strong><em> Clinical Experience / Clinical Utility, 2021, Belgium, RAAs, CNVs</em></p>
<ul>
<li>Belgium was the first country to implement and fully reimburse NIPT as a first-tier screening for all pregnant women. In this publication, a consortium comprised of all the Belgian genetic center reports on the clinical experience during a 2-year period of offering Expanded NIPT as a first-tier testing option for all pregnant women. Of the 153,575 pregnancies screened, rare autosomal trisomies and partial deletions/duplications were found in 0.23% and 0.07% of cases, respectively. Invasive diagnostic obstetric procedures decreased by 52%. The authors conclude that their Expanded NIPT approach has been successfully implemented into prenatal care in Belgium and could possibly act as a framework for other countries offering NIPT.</li>
</ul>
<p>The post <a href="https://niptconsortium.com/outcome-of-publicly-funded-nationwide-first-tier-noninvasive-prenatal-screening/">Outcome of publicly funded nationwide first-tier noninvasive prenatal screening</a> appeared first on <a href="https://niptconsortium.com">Global NIPT Consortium</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
